Total Payments
$20,111
2024 Payments
$1,919
Companies
66
Transactions
1,332
Medicare Patients
19,014
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$20,001 (99.4%)
Education$59.16 (0.3%)
Other$51.67 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,001 | 1,323 | 99.4% |
| Education | $59.16 | 7 | 0.3% |
| Entertainment | $40.00 | 1 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11.67 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,532 | 242 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,980 | 100 | $0 (2023) |
| Novo Nordisk Inc | $1,399 | 100 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,319 | 56 | $0 (2024) |
| Abbott Laboratories | $1,274 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $1,014 | 86 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $963.63 | 48 | $0 (2024) |
| Boston Scientific Corporation | $951.46 | 29 | $0 (2024) |
| Amgen Inc. | $875.26 | 62 | $0 (2023) |
| Merck Sharp & Dohme LLC | $857.14 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,919 | 64 | Abbott Laboratories ($283.64) |
| 2023 | $1,948 | 85 | Novartis Pharmaceuticals Corporation ($331.24) |
| 2022 | $2,952 | 102 | Abbott Laboratories ($842.27) |
| 2021 | $1,972 | 115 | AstraZeneca Pharmaceuticals LP ($305.84) |
| 2020 | $2,407 | 163 | AstraZeneca Pharmaceuticals LP ($325.08) |
| 2019 | $3,018 | 219 | Novartis Pharmaceuticals Corporation ($335.54) |
| 2018 | $2,882 | 302 | Novartis Pharmaceuticals Corporation ($350.34) |
| 2017 | $3,013 | 282 | Novartis Pharmaceuticals Corporation ($594.70) |
All Payment Transactions
1,332 individual payment records from CMS Open Payments — Page 3 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Neurology | ||||||
| 03/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Cardio-renal | ||||||
| 03/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $60.86 | General |
| Category: Coronary | ||||||
| 02/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $113.57 | General |
| Category: DIABETES | ||||||
| 01/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $138.65 | General |
| Category: Vascular | ||||||
| 12/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Cardiovascular | ||||||
| 12/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DIABETES | ||||||
| 12/01/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/29/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: Cardiology | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2023 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Rare Disease | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Not Applicable | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 54 | 4,805 | 20,518 | $2.4M | $681,804 |
| 2022 | 58 | 4,457 | 18,405 | $2.2M | $656,065 |
| 2021 | 55 | 5,056 | 19,711 | $2.4M | $739,832 |
| 2020 | 47 | 4,696 | 19,312 | $2.4M | $694,131 |
Total Patients
19,014
Total Services
77,946
Medicare Billing
$2.8M
Procedure Codes
214
All Medicare Procedures & Services
214 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 1,731 | $190,410 | $117,819 | 61.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 188 | 191 | $382,000 | $76,819 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 346 | 710 | $133,270 | $69,520 | 52.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 355 | 389 | $311,200 | $66,890 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 260 | 480 | $72,000 | $36,229 | 50.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 156 | 229 | $49,235 | $25,105 | 51.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 239 | $37,045 | $24,490 | 66.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 189 | 196 | $76,800 | $23,360 | 30.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 91 | 92 | $55,200 | $20,130 | 36.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 103 | 104 | $72,800 | $15,922 | 21.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 231 | 269 | $94,150 | $14,963 | 15.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 122 | 124 | $22,320 | $13,534 | 60.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 126 | 192 | $21,120 | $13,404 | 63.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 35 | 249 | $19,920 | $10,715 | 53.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 404 | 826 | $70,210 | $9,893 | 14.1% |
| 93931 | Ultrasound of one arm arteries or artery grafts | Office | 2023 | 94 | 95 | $20,425 | $8,689 | 42.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 33 | $12,375 | $8,123 | 65.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $12,880 | $7,761 | 60.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 29 | 162 | $19,440 | $7,490 | 38.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 97 | 108 | $18,900 | $7,129 | 37.7% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 62 | 63 | $47,250 | $7,068 | 15.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 107 | 110 | $12,100 | $5,818 | 48.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 139 | 143 | $12,870 | $5,757 | 44.7% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 26 | 26 | $14,300 | $5,355 | 37.5% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 26 | 26 | $14,300 | $5,140 | 35.9% |
About Dr. Gitendra Rajiyah, MD
Dr. Gitendra Rajiyah, MD is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083693196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gitendra Rajiyah, MD has received a total of $20,111 in payments from pharmaceutical and medical device companies, with $1,919 received in 2024. These payments were reported across 1,332 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($20,001).
As a Medicare-enrolled provider, Rajiyah has provided services to 19,014 Medicare beneficiaries, totaling 77,946 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 214 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location East Orange, NJ
- Active Since 01/17/2006
- Last Updated 07/30/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083693196
Products in Payments
- ENTRESTO (Drug) $2,277
- LifeVest (Device) $1,319
- Vascepa (Drug) $1,014
- JARDIANCE (Drug) $871.68
- FARXIGA (Drug) $597.28
- Repatha (Biological) $596.17
- XARELTO (Drug) $561.55
- BRILINTA (Drug) $491.43
- Kerendia (Drug) $441.80
- WATCHMAN (Device) $433.54
- LONHALA MAGNAIR (Drug) $378.24
- TRELEGY ELLIPTA (Drug) $376.59
- Ozempic (Drug) $360.27
- SYMBICORT (Drug) $355.05
- JANUVIA (Drug) $337.48
- Livalo (Drug) $330.05
- ELIQUIS (Drug) $321.17
- TRULICITY (Drug) $290.11
- VERQUVO (Drug) $283.04
- Victoza (Drug) $263.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Orange
Dr. Alexander Salerno, Md, MD
Internal Medicine — Payments: $73,770
Internal Medicine $73,770
Eddy Simon, Md, MD
Internal Medicine — Payments: $7,943
Internal Medicine $7,943
Dr. Anand Srinivasan, Md, MD
Internal Medicine — Payments: $7,905
Internal Medicine $7,905
Dr. Radhika Maddali, Md, MD
Internal Medicine — Payments: $6,737
Internal Medicine $6,737
Dr. Mamatha Mohan, M.d, M.D
Internal Medicine — Payments: $6,050
Internal Medicine $6,050
Robert Clarke, Md, MD
Internal Medicine — Payments: $5,522
Internal Medicine $5,522